IEEE Reviews in Biomedical Engineering

IEEE Reviews in Biomedical Engineering is a peer-reviewed review journal published by the Institute of Electrical and Electronics Engineers and sponsored by its Engineering in Medicine and Biology Society, established in 2008, with a 2025 Journal Impact Factor of 16.0《IEEE 生物医学工程评论》是由（IEEE）出版、并由其（Engineering in Medicine and Biology Society）主办的同行评审综述期刊，2008 年创刊，2025 年影响因子为 16.0。

Scope

• It publishes comprehensive review articles that evaluate major developments and critically assess recent advances across biomedical engineering该刊发表评估生物医学工程重大进展并审慎评述近期突破的综合综述文章。
• It covers artificial intelligence and deep learning in medicine and healthcare该刊涵盖面向医学与医疗保健的人工智能与深度学习。^[1]
• It covers wearable, diagnostic and implantable technologies as well as rehabilitation engineering该刊涵盖可穿戴、诊断与植入式技术以及康复工程。
• It covers neuroengineering, neurotechnology, biomedical imaging and signal processing该刊涵盖神经工程、神经技术、生物医学成像与信号处理。
• Its scope spans biomedical robotics, medical devices, health informatics and computational biomedicine其范围横跨生物医学机器人、医疗器械、健康信息学与计算生物医学。
• It also covers biomedical microsystems, tissue and cellular engineering, biomaterials, immunoengineering and genetic engineering该刊还涵盖生物医学微系统、组织与细胞工程、生物材料、免疫工程与基因工程。^[2]
• Unlike primary research journals, it consolidates existing knowledge and identifies emerging directions与原创研究期刊不同，该刊重在梳理既有知识并指出新兴方向。

History

• It was established in 2008 and has since been published under the auspices of the IEEE Engineering in Medicine and Biology Society该刊于 2008 年创刊，此后在（IEEE Engineering in Medicine and Biology Society）主持下持续出版。^[3]
• Its first volume appeared in 2008 and the title has been indexed in Web of Science since then其首卷于 2008 年出版，此后被（Web of Science）收录。
• It issues one volume per year instead of regular monthly numbers该刊每年出版一卷，而非按月发行。
• It has always been devoted to review and survey articles rather than original experimental reports该刊始终专注综述与调查报告，而非原创实验论文。
• Its Journal Impact Factor was 7.073 in 2022 and rose to 12.0 in 2024 and 16.0 in 2025其影响因子 2022 年为 7.073，2024 年升至 12.0，2025 年为 16.0。
• Articles are screened for plagiarism and evaluated by at least two independent reviewers under single or double anonymous review其稿件经抄袭筛查，并由至少两名独立评审人在单盲或双盲流程下评估。

Editors

• Its Editor-in-Chief is Bin He of Carnegie Mellon University其主编为（Carnegie Mellon University）的 Bin He。
• He has served as Editor-in-Chief since 2023他自 2023 年起担任主编。
• Its founding Editor-in-Chief was Jose C. Principe of the University of Florida其创刊主编为（University of Florida）的 Jose C. Principe。
• Yuanting Zhang served as Editor-in-Chief from 2016Yuanting Zhang 自 2016 年起担任主编。
• Its Managing Editor is Wendy Ye其执行编辑为 Wendy Ye。
• Each manuscript is handled by an editorial board member who selects the independent reviewers每篇稿件由一名编委负责处理并选定独立评审人。